← Back to Clinical Trials
Recruiting NCT06753409

NCT06753409 Processed Electroencephalography-guided General Anesthesia and Outcomes in Major Abdominal Surgery

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06753409
Status Recruiting
Phase
Sponsor Assiut University
Condition Postoperative Acute Kidney Injury
Study Type INTERVENTIONAL
Enrollment 162 participants
Start Date 2025-02-01
Primary Completion 2026-12-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 70 Years
Study Type INTERVENTIONAL
Interventions
Processed electroencephalography (pEEG) Guided General AnesthesiaNon-pEEG-Guided General Anesthesia (with blinded pEEG monitoring)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 162 participants in total. It began in 2025-02-01 with a primary completion date of 2026-12-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study aims to evaluate whether the reduction in the amount of intraoperative norepinephrine required to prevent hypotension, facilitated by processed electroencephalography (pEEG) -guided general anesthesia, will lead to a decrease in postoperative complications, particularly acute kidney injury (AKI).

Eligibility Criteria

Inclusion Criteria: 1. Patients scheduled for major abdominal surgery lasting more than 2 hours under general anesthesia. 2. American Society of Anesthesiologists Physical Status (ASA) score I-III. 3. Age range of 18-70 years. 4. Both male and female patients. Exclusion Criteria: 1. Emergency surgeries. 2. Uncontrolled hypertension (systolic blood pressure \>150 mm Hg) despite medication. 3. Recent acute cardiovascular events, including heart failure or acute coronary syndrome. 4. Chronic kidney disease with a glomerular filtration rate \<30 ml/min/1.73 m² or requiring renal replacement therapy. 5. Severe hepatic failure (ASAT/ALAT \>2N, elevated bilirubin, or PT \<50%). 6. Preoperative sepsis or septic shock. 7. Pregnancy. 8. Patient refusal to participate in the study.

Contact & Investigator

Central Contact

Walaa H Mohamed, Assistant Lecturer

✉ walaa95.hamdy@gmail.com

📞 +201061403338

Frequently Asked Questions

Who can join the NCT06753409 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 70 Years, studying Postoperative Acute Kidney Injury. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06753409 currently recruiting?

Yes, NCT06753409 is actively recruiting participants. Contact the research team at walaa95.hamdy@gmail.com for enrollment information.

Where is the NCT06753409 trial being conducted?

This trial is being conducted at Asyut, Egypt.

Who is sponsoring the NCT06753409 clinical trial?

NCT06753409 is sponsored by Assiut University. The trial plans to enroll 162 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology